
Cathy Fong Fong Lam
Examiner (ID: 6825)
| Most Active Art Unit | 1775 |
| Art Unit(s) | 1775, 1784, 1508, 1794, 1513, 1774, CSDC, 1317 |
| Total Applications | 1786 |
| Issued Applications | 1378 |
| Pending Applications | 45 |
| Abandoned Applications | 364 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8173467
[patent_doc_number] => 20120108464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'TEST SYSTEMS, METHODS AND USES INVOLVING AS160 PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 13/142869
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12339
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108464.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142869
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142869 | TEST SYSTEMS, METHODS AND USES INVOLVING AS160 PROTEIN | Jan 26, 2010 | Abandoned |
Array
(
[id] => 6426843
[patent_doc_number] => 20100168231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'TARGET ENZYME FOR THE TREATMENT OF ACNE'
[patent_app_type] => utility
[patent_app_number] => 12/652283
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4223
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168231.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652283
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652283 | TARGET ENZYME FOR THE TREATMENT OF ACNE | Jan 4, 2010 | Abandoned |
Array
(
[id] => 6323854
[patent_doc_number] => 20100197020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'TISSUE ENGINEERING TENDON AND CONSTRUCTION METHODS IN VITRO THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/648827
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6324
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197020.pdf
[firstpage_image] =>[orig_patent_app_number] => 12648827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/648827 | TISSUE ENGINEERING TENDON AND CONSTRUCTION METHODS IN VITRO THEREOF | Dec 28, 2009 | Abandoned |
Array
(
[id] => 7485760
[patent_doc_number] => 20110250606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'METHOD FOR THE IDENTIFICATION OF CARCINOGENIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/998915
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10383
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20110250606.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998915 | Method for the identification of carcinogenic compounds | Dec 16, 2009 | Issued |
Array
(
[id] => 9140055
[patent_doc_number] => 08580512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 13/063865
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 23
[patent_no_of_words] => 11274
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063865
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063865 | Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases | Nov 19, 2009 | Issued |
Array
(
[id] => 10032899
[patent_doc_number] => 09074206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Compositions and methods for micro-RNA expression profiling of colorectal cancer'
[patent_app_type] => utility
[patent_app_number] => 13/129289
[patent_app_country] => US
[patent_app_date] => 2009-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 13
[patent_no_of_words] => 31725
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129289
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129289 | Compositions and methods for micro-RNA expression profiling of colorectal cancer | Nov 12, 2009 | Issued |
Array
(
[id] => 6228847
[patent_doc_number] => 20100183585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING TUMORS AND METASTASES THROUGH THE MODULATION OF LATEXIN'
[patent_app_type] => utility
[patent_app_number] => 12/608376
[patent_app_country] => US
[patent_app_date] => 2009-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15921
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183585.pdf
[firstpage_image] =>[orig_patent_app_number] => 12608376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/608376 | METHODS AND COMPOSITIONS FOR TREATING TUMORS AND METASTASES THROUGH THE MODULATION OF LATEXIN | Oct 28, 2009 | Abandoned |
Array
(
[id] => 7784622
[patent_doc_number] => 20120046178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/126684
[patent_app_country] => US
[patent_app_date] => 2009-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 25624
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046178.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126684
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126684 | PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION | Oct 26, 2009 | Abandoned |
Array
(
[id] => 5937259
[patent_doc_number] => 20110212849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'BIOMARKERS FOR PREDICTING THE DEVELOPMENT OF CHRONIC AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/998478
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17002
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998478
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998478 | BIOMARKERS FOR PREDICTING THE DEVELOPMENT OF CHRONIC AUTOIMMUNE DISEASES | Oct 25, 2009 | Abandoned |
Array
(
[id] => 7500337
[patent_doc_number] => 20110262905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'KIT FOR THE OPTIMISATION OF PROTEIN SYNTHESIS/SECRETION'
[patent_app_type] => utility
[patent_app_number] => 13/122378
[patent_app_country] => US
[patent_app_date] => 2009-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5668
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262905.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122378
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122378 | Kit for the optimisation of protein synthesis/secretion | Sep 30, 2009 | Issued |
Array
(
[id] => 7488692
[patent_doc_number] => 20110236928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Methods for producing polypeptides in enzyme-deficient mutants of fusarium venenatum'
[patent_app_type] => utility
[patent_app_number] => 13/121254
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 34715
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236928.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121254
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121254 | Methods for producing polypeptides in enzyme-deficient mutants of Fusarium venenatum | Sep 29, 2009 | Issued |
Array
(
[id] => 8065011
[patent_doc_number] => 20110244515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'METHOD OF PREPARING PROTEIN HAVING HIGH CONTENT OF SPECIFIC AMINO ACID BY CO-EXPRESSION WITH TRNA OF SPECIFIC AMINO ACID'
[patent_app_type] => utility
[patent_app_number] => 13/120404
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5453
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20110244515.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120404 | METHOD OF PREPARING PROTEIN HAVING HIGH CONTENT OF SPECIFIC AMINO ACID BY CO-EXPRESSION WITH TRNA OF SPECIFIC AMINO ACID | Sep 21, 2009 | Abandoned |
Array
(
[id] => 7501382
[patent_doc_number] => 20110263449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'IN VITRO METHOD AND KIT FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-ALPHA FACTOR BLOCKING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/120445
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3833
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263449.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120445 | In vitro method and kit for prognosis or prediction of response by patients with rheumatoid arthritis to treatment with TNF-αfactor blocking agents | Sep 17, 2009 | Issued |
Array
(
[id] => 7488684
[patent_doc_number] => 20110236927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'GENETICALLY STABILIZED TANDEM GENE DUPLICATION'
[patent_app_type] => utility
[patent_app_number] => 13/060822
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20898
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236927.pdf
[firstpage_image] =>[orig_patent_app_number] => 13060822
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060822 | GENETICALLY STABILIZED TANDEM GENE DUPLICATION | Aug 26, 2009 | Abandoned |
Array
(
[id] => 6048304
[patent_doc_number] => 20110207627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'EX VIVO THERAPEUTICS SCREENING OF LIVING BONE MARROW CELLS FOR MULTIPLE MYELOMA'
[patent_app_type] => utility
[patent_app_number] => 13/057978
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5787
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207627.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057978
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057978 | EX VIVO THERAPEUTICS SCREENING OF LIVING BONE MARROW CELLS FOR MULTIPLE MYELOMA | Aug 11, 2009 | Abandoned |
Array
(
[id] => 7574169
[patent_doc_number] => 20110269825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Modified Thromboxane A2 Receptor Promoter Sequence'
[patent_app_type] => utility
[patent_app_number] => 13/058716
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 32900
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269825.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058716
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058716 | Modified Thromboxane A2 Receptor Promoter Sequence | Aug 10, 2009 | Abandoned |
Array
(
[id] => 6166901
[patent_doc_number] => 20110195847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'METHODS TO TREAT SOLID TUMORS'
[patent_app_type] => utility
[patent_app_number] => 12/996754
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25123
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195847.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996754 | METHODS TO TREAT SOLID TUMORS | Jun 11, 2009 | Abandoned |
Array
(
[id] => 8211050
[patent_doc_number] => 20120129721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'URINARY GM2 ACTIVATOR PROTEIN AS A MARKER OF ACUTE RENAL FAILURE OR THE RISK OF DEVELOPING ACUTE RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 13/322378
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10348
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129721.pdf
[firstpage_image] =>[orig_patent_app_number] => 13322378
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322378 | URINARY GM2 ACTIVATOR PROTEIN AS A MARKER OF ACUTE RENAL FAILURE OR THE RISK OF DEVELOPING ACUTE RENAL FAILURE | May 25, 2009 | Abandoned |
Array
(
[id] => 9020221
[patent_doc_number] => 08530206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Method for the production of medium-chain sophorolipids'
[patent_app_type] => utility
[patent_app_number] => 12/994077
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8048
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994077
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994077 | Method for the production of medium-chain sophorolipids | May 19, 2009 | Issued |
Array
(
[id] => 6177227
[patent_doc_number] => 20110177965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROGNOSIS OF GASTRIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/994411
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12803
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177965.pdf
[firstpage_image] =>[orig_patent_app_number] => 12994411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994411 | Compositions and methods for prognosis of gastric cancer | May 18, 2009 | Issued |